Sartorius Stedim Biotech S.A. (EPA:DIM)
217.20
+0.60 (0.28%)
Sep 29, 2026, 5:35 PM CET
Sartorius Stedim Biotech Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains €210.00 → €240.00 | Buy | Maintains | €210.00 → €240.00 | +10.50% | Sep 8, 2026 |
| UBS | UBS | Buy Upgrades €220.00 → €260.00 | Buy | Upgrades | €220.00 → €260.00 | +19.71% | Aug 20, 2026 |
| RBC Capital | RBC Capital | Buy Maintains €210.00 | Buy | Maintains | €210.00 | -3.31% | Aug 12, 2026 |
| Bernstein | Bernstein | Buy Maintains €245.00 → €230.00 | Buy | Maintains | €245.00 → €230.00 | +5.89% | Jul 28, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains €260.00 | Buy | Maintains | €260.00 | +19.71% | Jul 24, 2026 |
| HSBC | HSBC | Buy Maintains €233.00 → €230.00 | Buy | Maintains | €233.00 → €230.00 | +5.89% | Jun 3, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains €214.00 | Buy | Maintains | €214.00 | -1.47% | Apr 23, 2026 |